These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Growing up with perinatal HIV infection: time for a HAART to heart. Siberry GK; Joyner M; Hutton N J Pediatr; 2008 Oct; 153(4):456-7. PubMed ID: 18847617 [No Abstract] [Full Text] [Related]
4. [Controversies and future of the approach to cardiovascular disease in HIV patients]. Bernardino de la Serna JI; Arribas López JR Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():48-53. PubMed ID: 20172415 [TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome, an epidemic among HIV-infected patients on HAART. Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676 [TBL] [Abstract][Full Text] [Related]
7. [Increased cardiovascular risk in HIV patients]. Wierema TK Ned Tijdschr Geneeskd; 2010; 154():A788. PubMed ID: 20456808 [TBL] [Abstract][Full Text] [Related]
8. Antiretrovirals and cardiovascular disease: is HAART bad for your heart? Fichtenbaum CJ AIDS Clin Care; 2003 Aug; 15(8):69-73, 76. PubMed ID: 12945527 [No Abstract] [Full Text] [Related]
9. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Bergersen BM; Sandvik L; Bruun JN; Tonstad S Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):625-30. PubMed ID: 15322938 [TBL] [Abstract][Full Text] [Related]
10. The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care. Samaras K Curr HIV/AIDS Rep; 2012 Sep; 9(3):206-17. PubMed ID: 22752405 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. Grinspoon S; Carr A N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112 [No Abstract] [Full Text] [Related]
14. Does antiretroviral-induced hyperlipidaemia constitute a cardiovascular risk? Gilleece Y; Nelson M J HIV Ther; 2001 May; 6(2):37-9. PubMed ID: 11501202 [No Abstract] [Full Text] [Related]
15. HIV and diabetes. Samarasinghe YP Prim Care Diabetes; 2007 Jun; 1(2):99-101. PubMed ID: 18632027 [No Abstract] [Full Text] [Related]
16. Optimal antiretroviral therapy for aging. Cordery DV; Cooper DA Sex Health; 2011 Dec; 8(4):534-40. PubMed ID: 22127040 [TBL] [Abstract][Full Text] [Related]
17. Metabolic and skeletal complications of HIV infection: the price of success. Morse CG; Kovacs JA JAMA; 2006 Aug; 296(7):844-54. PubMed ID: 16905789 [TBL] [Abstract][Full Text] [Related]
18. HIV and cardiovascular risk factors. Falusi OM; Aberg JA AIDS Read; 2001 May; 11(5):263-8. PubMed ID: 11392695 [TBL] [Abstract][Full Text] [Related]
19. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy. Mondy KE; Gottdiener J; Overton ET; Henry K; Bush T; Conley L; Hammer J; Carpenter CC; Kojic E; Patel P; Brooks JT; Clin Infect Dis; 2011 Feb; 52(3):378-86. PubMed ID: 21217185 [TBL] [Abstract][Full Text] [Related]
20. Risk of cardiovascular disease in HIV-infected patients. Das S J Antimicrob Chemother; 2010 Mar; 65(3):386-9. PubMed ID: 20026610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]